血浆透析滤过治疗时间对肝衰竭治疗效果的影响

杨仙珊; 周莉; 李璐; 李爽; 孔明; 李珊珊; 邹怀宾; 徐曼曼

doi:10.3969/j.issn.1001-5256.2018.05.025

血浆透析滤过治疗时间对肝衰竭治疗效果的影响

DOI: 10.3969/j.issn.1001-5256.2018.05.025

首都医科大学附属北京佑安医院人工肝中心

基金项目:

国家科技重大专项(2017ZX10203201-005,2017ZX10201201,2017ZX10302201-004-002,2017ZX10202203-006-001)； 2016年度院内中青年人才孵育项目(YNKT20160028,YNKT20160017)；

详细信息

中图分类号: R575.3
计量
- 文章访问数: 2853
- HTML全文浏览量: 64
- PDF下载量: 393
- 被引次数: 0
出版历程
- 收稿日期: 2017-09-20
- 出版日期: 2018-05-20

Influence of duration of plasma diafiltration on therapeutic outcome of liver failure

Artificial Liver Treatment & Training Center, Beijing YouAn Hospital, Capital Medical University

Research funding:

摘要

摘要: 目的探讨血浆透析滤过（PDF）治疗时间的长短对肝衰竭患者肝功能的影响以及对治疗后肝功能反弹的影响。方法选择2015年1月-2016年12月首都医科大学附属北京佑安医院收治的肝衰竭患者101例,按照治疗时间分为2组,治疗4 h组77例,治疗6 h组24例,均在内科治疗的基础上行人工肝治疗。观察2组治疗前后ALT、AST、TBil、DBil下降幅度及治疗后24 h、治疗后72 h的ALT、AST、TBil、DBil反弹幅度。计量资料2组间比较采用t检验,计数资料组间比较采用χ2检验。结果 2组患者治疗过程中血流动力学稳定,无不良事件发生,部分患者诉平卧时间长,感觉乏力,4 h组5例不耐受,不耐受率6.5%,6 h组10例,不耐受率41.7%,显著高于4 h组（χ2=17.90,P<0.01）。PDF治疗后,2组ALT、AST、TBil、DBil下降幅度差异均无统计学意义（t值分别为2.53、-4.48、-1.52、-0.47,P值均>0.05）。2组治疗后24 h ALT、AST、TBil、DBil反弹幅度差异均无统计学意义（t值分别为-0.236、-1.251、-1.251、...
- 肝功能衰竭 /
- 血液透析滤过 /
- 肝,人工
Abstract: Objective To investigate the influence of different durations of plasma diafiltration ( PDF) on liver function in patients with liver failure and rebound of liver function after treatment. Methods A total of 101 patients with liver failure who were admitted to Beijing You An Hospital, Capital Medical University, from January 2015 to December 2016 were enrolled, and according to the duration of treatment, these patients were divided into 4-hour group with 77 patients and 6-hour group with 24 patients. All patients were given artificial extracorporeal liver support therapy in addition to the medical treatment. The two groups were observed in terms of the reductions in alanine aminotransferase ( ALT) , aspartate aminotransferase ( AST) , total bilirubin ( TBil) , and direct bilirubin ( DBil) after treatment and the rebound of ALT, AST, TBil, and DBil at 24 and 72 hours after treatment. The t-test was used for comparison of continuous data between groups, and the chi-square test was used for comparison of categorical data between groups. Results All patients had stable hemodynamics during treatment and no patient experienced adverse events. Some patients complained of staying in bed for a long time and feeling weak. The 6-hour group had a significantly higher intolerance rate than the 4-hour group [41. 7% ( 10/24) vs 6. 5% ( 5/77) , χ2= 17. 90, P < 0. 01].There were no significant differences in the reductions in ALT, AST, TBil, and DBil after PDF treatment between the two groups ( t = 2. 53, -4. 48, -1. 52, and-0. 47, all P > 0. 05) . There were also no significant differences between the two groups in the degrees of rebound of ALT, AST, TBil, and DBil at 24 and 72 hours after treatment ( 24 hours: t =-0. 236, -1. 251, -1. 251, and 0. 943, all P > 0. 05;72 hours: t =-0. 700, 0. 596, -1. 530, and 1. 837, all P > 0. 05) . Conclusion PDF treatment with different durations has similar effect and safety. Therefore, 4-hour PDF can be applied in clinical practice to improve patients' tolerance.
- liver failure /
- hemodiafiltration /
- liver, artificial

HTML全文

参考文献(14)

[1] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association;Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association.Guidelines for diagnosis and treatment liver failure[J].Chin J Clin Infect Dis, 2012, 5 (6) :321-327. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南 (2012年版) [J].中华临床感染病杂志, 2012, 5 (6) :321-327.

[2]YOSHIBA M, SEKIYAMA K, IWAMURA Y, et al.Development of reliable artificial liver support (ALS) ——plasma exchange in combination with hemodiafiltration using high-performance membranes[J].Dig Dis Sci, 1993, 38 (3) :469-476.

[3]CHEN Y, DUAN ZP.The application of artificial liver support system in the treatment of severe hepatitis and liver failure[J].J Clin Intern Med, 2008, 25 (11) :299-301. (in Chinese) 陈煜, 段钟平.人工肝支持系统在重症肝炎和肝衰竭治疗中的应用[J].临床内科杂志, 2008, 25 (11) :299-301.

[4]YANG JL, HUANG JR.Application of artificial liver support system in treatment of liver failure[J].J Clin Hepatol, 2015, 31 (9) :1405-1410. (in Chinese) 杨建乐, 黄建荣.人工肝支持系统在肝衰竭治疗中的应用[J].临床肝胆病杂志, 2015, 31 (9) :1405-1410.

[5]YU YW, LI MX, DONG Z.Clinical application of plasma exchange combined with hemodiafiltration in patients with liver failure[J].Chin J Blood Purificat, 2009, 8 (5) :267-269. (in Chinese) 余永武, 李明旭, 董珍.血浆置换联合血液透析滤过治疗肝衰竭的临床应用[J].中国血液净化, 2009, 8 (5) :267-269.

[6]YU GQ, ZENG JH, XUAN JH, et al.Plasma exchange and hemodialysis filtration intreatment of patients with fulminan the patitis[J].J Pract Hepatol, 2010, 13 (5) :352-353. (in Chinese) 郁国强, 曾军红, 禤江华, 等.血浆置换联合血液透析滤过治疗重型肝炎的临床观察[J].实用肝脏病杂志, 2010, 13 (5) :352-353.

[7]LIN JH, GUO YX, ZHOU XH, et al.Change of blood parameters in liver failure patients with severe hepatitis after combine therapy[J].Chin Critical Care Med, 2003, 15 (2) :103-105. (in Chinese) 林加豪, 郭艳雪, 周秀华, 等.血浆置换联合高通量血液透析滤过治疗重症肝炎肝脏衰竭临床研究[J].中国危重病急救医学, 2003, 15 (2) :103-105.

[8]SUN XZ, CHEN JG.Clinical application of plasma exchange combined with hemodiafiltration in severe hepatitis patients with hepatorenal syndrome[J/CD].Chin J Clinicians:Electronic Edition, 2011, 5 (15) :4545-4546. (in Chinese) 孙西照, 陈进国.血浆置换联合血液透析滤过治疗重型肝炎肝肾综合征临床观察[J/CD].中华临床医师杂志:电子版, 2011, 5 (15) :4545-4546.

[9]CHEN N, WANG JF, QIAN ZP, et al.Continuity of plasma dialysis filter in the treatment of acute liver failure clinical curative effect evaluation[J].Chin Hepatol, 2015, 20 (1) :54-56. (in Chinese) 陈楠, 王介非, 钱志平, 等.连续性血浆透析滤过在急性肝衰竭治疗中的临床疗效评价[J].肝脏, 2015, 20 (1) :54-56.

[10]XING HQ, LIU JW, WANG KL, et al.Analysis of clinical effect of comtinuous plasma diafiltration for the therapy of liver failure[J].BMA&Clin Med, 2013, 17 (2) :152-155. (in Chinese) 邢汉前, 刘俊微, 王开利, 等.持续缓慢血浆透析滤过治疗肝功能衰竭的临床疗效分析[J].生物医学工程与临床, 2013, 17 (2) :152-155.

[11]LI S, CHEN Y.Coping with shortage of plasma-The new therapeutic pattern of non-bioartificial liver[J].J Clin Hepatol, 2017, 33 (9) :1687-1692. (in Chinese) 李爽, 陈煜.血浆紧缺情况下非生物型人工肝治疗新模式的探讨[J].临床肝胆病杂志, 2017, 33 (9) :1687-1692.

[12]KONDRUP J, ALMADAL T, VILSTRUP H, et al.High volume plasma exchange in fulminant hepatic failure[J].Int J Artif Organs, 1992, 15 (2) :669-676.

[13]CLEMMESEN JO, KONDRUP J, NIELSEN LB, et al.Effects of high-volume plasmapheresis on ammonia, urea, and amino acids in patients with acute liverfailure[J].Am J Gastroenterol, 2001, 96 (4) :1217-1223.

[14]GONG DH, JI DX, XU B, et al.The application of sodium citrate anticoagulant in the continuous blood purification treatment of critically ill patient[J].Chin J Intern Med, 2003, 42 (1) :121-122. (in Chinese) 龚德华, 季大玺, 徐斌, 等.枸橼酸钠抗凝在重危患者连续性血液净化治疗中的应用[J].中华内科杂志, 2003, 42 (1) :121-122.

施引文献

资源附件(0)

访问统计